Steroid Stocks on the Rise: Ad Systems Communications, Inc., Neoprobe Corporation, and Norsat International Inc. Experience Significant Growth

Strategic Insights -

Ad Systems Communications, Inc. (OTCBB: ADSY) is a digital media and video communications services company that has recently announced an agreement with Resort Media Group to install its proprietary cable TV ad insertion technology into 10,000 time share rooms in North America. This contract names Ad Systems Communications, Inc. as the exclusive cable advertising sales company for Resort Media Group. The company's strategic plan includes capturing ad dollars targeted to the high-end television audience, and this agreement represents a fundamental building block in achieving this goal.

Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, has completed the preliminary review of information to be contained in the chemistry, manufacturing, and control (CMC) module of its proposed New Drug Application (NDA) for Lymphoseek(R) with the U.S. Food and Drug Administration (FDA). The CMC review with FDA follows earlier reviews of the clinical and pre-clinical data module components under the current Investigational New Drug (IND) process.

Norsat International Inc. (NII - TSX)(NSATF - OTCBB), a leading provider of intelligent satellite solutions, has been ranked in the Top 100 Companies in British Columbia by BC Business Magazine. Norsat was cited three times: #98 in the Top 100 Public Companies in BC, #8 in the Biggest Profit Gains amongst public companies, and #16 in Biggest Growth amongst public companies.

Key Takeaways:

  • Ad Systems Communications, Inc. has entered into an agreement with Resort Media Group to install its proprietary cable TV ad insertion technology into 10,000 time share rooms in North America.
  • Neoprobe Corporation has completed the preliminary review of the CMC module of the proposed NDA for Lymphoseek(R) with the FDA, a significant step in the proactive review process.
  • Norsat International Inc. has been ranked in the Top 100 Companies in British Columbia by BC Business Magazine, citing Norsat three times in various categories.
  • Ad Systems Communications, Inc.'s strategic plan includes capturing ad dollars targeted to the high-end television audience, and this agreement represents a fundamental building block in achieving this goal.
  • Neoprobe's Lymphoseek(R) regulatory clearance is expected to facilitate an expeditious review by the FDA.
  • Norsat's ranking in the Top 100 Companies in British Columbia reflects the hard efforts and devotion of its employees in providing superior products and services.
  • SteroidStocks.com has published an analysis report on the three companies, highlighting their growth potential.

Statistics:

  • 10,000 time share rooms in North America will be equipped with Ad Systems Communications, Inc.'s proprietary cable TV ad insertion technology.
  • Neoprobe Corporation has completed the preliminary review of the CMC module of the proposed NDA for Lymphoseek(R) with the FDA.
  • Norsat International Inc. has been ranked #98 in the Top 100 Public Companies in BC, #8 in the Biggest Profit Gains amongst public companies, and #16 in Biggest Growth amongst public companies.

Sources:

  • Ad Systems Communications, Inc. (OTCBB: ADSY)
  • Neoprobe Corporation (OTCBB: NEOP)
  • Norsat International Inc. (NII - TSX)(NSATF - OTCBB)
  • SteroidStocks.com
  • M2 PressWIRE
  • BC Business Magazine